DEFINITIVE CONTRACT

EVALUATE LIMITED - EVALUATE PHARMA SUBSCRIPTION

PIID: 29FTC124C0075
Effective Date: Sep 27, 2024End Date: Closed on Sep 26, 2025

Key Details

Dollars Obligated
$23,000
Awarding Sub-Agency
Federal Trade Commission
NAICS Code
518210
Place of Performance
DC

Description

EVALUATE PHARMA SUBSCRIPTION

Context & Analysis

Federal Trade Commission obligated $23,000 to EVALUATE LIMITED for evaluate pharma subscription. The award is classified under NAICS 518210 and issued as a definitive contract contract. Performance is located in DC. This award is one of several similar procurements from Federal Trade Commission under NAICS 518210 — related awards are listed below.

Contractor Information

Contractor: EVALUATE LIMITED
UEI: VSNLUM7NH161

Stay Updated

Get notified about new opportunities matching your interests.

Related